TY - JOUR
T1 - Correction
T2 - Novel formulations of oral bisphosphonates in the treatment of osteoporosis (Aging Clinical and Experimental Research, (2022), 34, 11, (2625-2634), 10.1007/s40520-022-02272-z)
AU - Fuggle, Nicholas
AU - Al-Daghri, Nasser
AU - Bock, Olivier
AU - Branco, Jaime
AU - Bruyère, Olivier
AU - Casado, Enrique
AU - Cavalier, Etienne
AU - Cortet, Bernard
AU - de Wit, Maarten
AU - Giusti, Andrea
AU - Halbout, Philippe
AU - Harvey, Nicholas C.
AU - Hiligsmann, Mickaël
AU - Kaufman, Jean Marc
AU - Kurth, Andreas
AU - Maggi, Stefania
AU - Matijevic, Radmila
AU - Minisola, Salvatore
AU - Palacios, Santiago
AU - Radermecker, Régis Pierre
AU - Thomasius, Friederike
AU - Tuzun, Sansin
AU - Veronese, Nicola
AU - Kanis, John A.
AU - Reginster, Jean Yves
AU - Rizzoli, René
AU - Cooper, Cyrus
PY - 2023
Y1 - 2023
N2 - In the published article, the author would like to update the following lines from Gastrointestinal adverse events were observed in 31% (n = 319) participants and, of these, 85% (n = 271) were upper gastrointestinal. to History of Gastrointestinal symptoms were observed in 31% (n = 319) participants and, of these, 85% (n = 271) were upper gastrointestinal in the published article. The original article has been updated.
AB - In the published article, the author would like to update the following lines from Gastrointestinal adverse events were observed in 31% (n = 319) participants and, of these, 85% (n = 271) were upper gastrointestinal. to History of Gastrointestinal symptoms were observed in 31% (n = 319) participants and, of these, 85% (n = 271) were upper gastrointestinal in the published article. The original article has been updated.
UR - http://www.scopus.com/inward/record.url?scp=85145560687&partnerID=8YFLogxK
U2 - 10.1007/s40520-022-02319-1
DO - 10.1007/s40520-022-02319-1
M3 - Comment/debate
C2 - 36595210
AN - SCOPUS:85145560687
JO - Aging Clinical and Experimental Research
JF - Aging Clinical and Experimental Research
SN - 1594-0667
ER -